Research article · 7 Feb 2026
Research articlePublished 1 Oct 2020
Prevalence and risk factors of severe bacterial infections in thalassemia patients.
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: Thalassemia is an inherited disease, and it is considered as one of the most common monogenic disorders that lead to chronic hemolytic anemia. Thalassemia is newly classified into non–transfusion-dependent thalassemia (NTDT), and transfusion-dependent thalassemia (TDT) based on the necessity of regular blood transfusions. Thalassemia major patients may need a chronic blood transfusion, iron chelation medication, and splenectomy as a part of their treatment. One of the most common causes of death in thalassemia patients is a bacterial infection. The predisposing factors of the infections are either related to the disease itself (e.g. anemia and reticuloendothelial system dysfunction) or to the treatment (e.g. splenectomy, transfusion-related infections, and iron chelation). Aim: To determine the prevalence and risk factors of severe bacterial infections in NTDT and TDT thalassemia patients at a tertiary hospital Method: A retrospective study was conducted on patients with NTDT & TDT. Records were scanned from 2014 to 2018 from the hematology department of a tertiary hospital, Jeddah, Saudi Arabia. Patients of all ages who had severe bacterial infection were included in this study. Results: This study was applied to a total of 231 thalassemia patients at a tertiary hospital in Jeddah, Saudi Arabia. 119 (51.5%) of them were females, and 112 (48.5%) were males; the mean age was 22 years (± SD 13.3). The majority of the patients were TDT 214 (92.6%), and 17 (7.4%) were NTDT. A total of 38 ( 16.5%) thalassemic patients admitted due to bacterial infection. Most of the patients get infected by Escherichia coli, Staphylococcus aureus, and Klebsiella pneumoniae with the percentage of (24.1%, 13.8%, 13.8%), respectively. Conclusion: In conclusion, Patients undergone splenectomies are not susceptible to bacterial infection. Deferoxamine or iron-chelating drugs does not increase the risk of bacterial infection in patients with thalassemia. Finally, a prophylactic antibiotic is not useful in decreasing bacterial infection in thalassemic patients.
Subjects
Paediatrics & NeonatologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Current Pediatric Research.
Research article · 17 Jan 2026
Risk Ratio of Death in Infants with Severe Acute Malnutrition (SAM) and Severe Underweight (SUW) from Nandurbar, Maharashtra India
Research article · 2 Sep 2025
Clinical profile and immediate outcome of ventilated neonates admitted in NICU of tertiary care hospital in central India.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCurrent Pediatric Research
- SubjectPaediatrics & Neonatology
- BylineArticles whose byline prints “Fatma S. Alzhrani”
- BylineArticles whose byline prints “Fatima A. Algethmi”
- BylineArticles whose byline prints “Manar A. Makin”
- BylineArticles whose byline prints “Nujud A. Barayan”
- BylineArticles whose byline prints “Rawan M. Hilal”
- BylineArticles whose byline prints “Sarah Matouk Alnakhli”
